Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.5 - $1.05 $25,550 - $53,655
51,100 New
51,100 $30,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.94 $7,599 - $15,684
-8,085 Reduced 56.52%
6,219 $6,000
Q1 2022

May 13, 2022

SELL
$1.54 - $3.71 $60,361 - $145,417
-39,196 Reduced 73.26%
14,304 $29,000
Q4 2021

Feb 11, 2022

SELL
$2.58 - $3.91 $339,270 - $514,165
-131,500 Reduced 71.08%
53,500 $142,000
Q3 2021

Nov 12, 2021

BUY
$2.77 - $4.05 $280,878 - $410,670
101,400 Added 121.29%
185,000 $627,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $67,887 - $164,358
39,700 Added 90.43%
83,600 $322,000
Q1 2021

May 17, 2021

BUY
$0.85 - $5.27 $37,315 - $231,352
43,900 New
43,900 $115,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $335M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.